Literature DB >> 27409497

Visual Function and Central Retinal Structure in Choroideremia.

Elise Heon1, Talal Alabduljalil2, David B McGuigan III3, Artur V Cideciyan3, Shuning Li4, Shiyi Chen5, Samuel G Jacobson3.   

Abstract

PURPOSE: To define the clinical phenotype of a cohort of patients affected with choroideremia.
METHODS: A retrospective study of patients with choroideremia included two centers. Data collected included age, visual acuity, refractive error, color vision, kinetic perimetry, optical coherence tomography (OCT), and genotype information.
RESULTS: Sixty male participants were recruited. Genotype information was available for 58 cases, and nonsense mutations were most commonly observed. Eight novel mutations were identified including a missense mutation. The mean age at the first visit was 30.1 years (range, 5-65 years) and thirty-seven patients (61%) had more than one visit with a mean follow-up period of 10.3 years (range, 1-23 years). Visual acuity was not associated with age for patients younger than 30 years (P = 0.46) but significantly associated with age for the age group above 30 years (P < 0.0001). Central retinal thickness was significantly associated with visual acuity (P = 0.03) and with age (P = 0.0014). The extent of visual field documented by kinetic perimetry showed a negative correlation with age to tested stimuli; the smallest target used (I-4e) showed the earliest and most rapid deterioration below the age of 20 years (P = 0.0032). Color vision was abnormal in 46.7% of cases (mean age, 36.3 years; range, 18-61 years), which was associated with older age (P = 0.0039). Central OCT images were abnormal in all cases, as early as age 10 years. Outer retinal tubulations were observed in all but five patients. No genotype-phenotype correlation was observed.
CONCLUSIONS: This comprehensive structural and functional characterization of a large cohort of patients with molecularly confirmed choroideremia indicates that certain parameters are not changing significantly with time while others are. The latter warrants a prospective natural history study, ultimately to be considered as outcome measures for interventional clinical trials.

Entities:  

Mesh:

Year:  2016        PMID: 27409497     DOI: 10.1167/iovs.15-18421

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  Visual Function at the Atrophic Border in Choroideremia Assessed with Adaptive Optics Microperimetry.

Authors:  William S Tuten; Grace K Vergilio; Gloria J Young; Jean Bennett; Albert M Maguire; Tomas S Aleman; David H Brainard; Jessica I W Morgan
Journal:  Ophthalmol Retina       Date:  2019-05-08

2.  Colour discrimination ellipses in choroideremia.

Authors:  Immanuel P Seitz; Jasleen K Jolly; M Dominik Fischer; Matthew P Simunovic
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-02-05       Impact factor: 3.117

3.  Long-term Natural History of Atrophy in Eyes with Choroideremia-A Systematic Review and Meta-analysis of Individual-Level Data.

Authors:  Liangbo L Shen; Aneesha Ahluwalia; Mengyuan Sun; Benjamin K Young; Holly K Grossetta Nardini; Lucian V Del Priore
Journal:  Ophthalmol Retina       Date:  2020-03-14

4.  Two-year progression analysis of RPE65 autosomal dominant retinitis pigmentosa.

Authors:  Ruben Jauregui; Karen Sophia Park; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2018-08       Impact factor: 1.803

5.  Natural History of the Central Structural Abnormalities in Choroideremia: A Prospective Cross-Sectional Study.

Authors:  Tomas S Aleman; Grace Han; Leona W Serrano; Nicole M Fuerst; Emily S Charlson; Denise J Pearson; Daniel C Chung; Anastasia Traband; Wei Pan; Gui-Shuang Ying; Jean Bennett; Albert M Maguire; Jessica I W Morgan
Journal:  Ophthalmology       Date:  2016-12-13       Impact factor: 12.079

6.  CHOROIDEREMIA: Retinal Degeneration With an Unmet Need.

Authors:  Mark E Pennesi; David G Birch; Jacque L Duncan; Jean Bennett; Aniz Girach
Journal:  Retina       Date:  2019-11       Impact factor: 4.256

7.  SCLERAL PITS IN CHOROIDEREMIA: Implications for Retinal Gene Therapy.

Authors:  Abdullah A Al-Qahtani; Shakoor Ba-Ali; Talal Alabduljalil; Aaron S Coyner; Rachel C Patel; Richard G Weleber; Aniz Girach; Søren K Christensen; Michael Larsen; Mark E Pennesi; Paul Yang
Journal:  Retina       Date:  2018-09       Impact factor: 4.256

8.  Optical coherence tomography (OCT) features of cystoid spaces in choroideremia (CHM).

Authors:  Vittoria Murro; Dario Pasquale Mucciolo; Dario Giorgio; Andrea Sodi; Ilaria Passerini; Giacomo Bacci; Sara Bargiacchi; Gianni Virgili; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-10-26       Impact factor: 3.117

Review 9.  Progress in treating inherited retinal diseases: Early subretinal gene therapy clinical trials and candidates for future initiatives.

Authors:  Alexandra V Garafalo; Artur V Cideciyan; Elise Héon; Rebecca Sheplock; Alexander Pearson; Caberry WeiYang Yu; Alexander Sumaroka; Gustavo D Aguirre; Samuel G Jacobson
Journal:  Prog Retin Eye Res       Date:  2019-12-30       Impact factor: 21.198

10.  Validating Ellipsoid Zone Area Measurement With Multimodal Imaging in Choroideremia.

Authors:  Yi Zhai; Sarah Oke; Ian M MacDonald
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.